Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Drug discovery: a historical perspective.

J Drews1

  • 1International Biomedicine Management Partners, Basel, Switzerland and Orbimed Advisors LLC, New York, NY 10017-2023, USA.

Science (New York, N.Y.)
|March 17, 2000
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Sensing glucose concentrations at GHz frequencies with a fully embedded Biomicro-electromechanical system (BioMEMS).

Journal of applied physics·2014
Same author

Levels of parotid and submandibular/sublingual salivary immunoglobulin A in response to experimental gingivitis in humans.

Clinical oral investigations·2004
Same author

[Mycotic aneurysms--A retrospective analysis].

Zentralblatt fur Chirurgie·2002
Same author

Jürgen Drews discusses the future of the industry. Interviewed by Rebecca N. Lawrence.

Drug discovery today·2001
Same author

Quo vadis, biotech? (Part 2).

Drug discovery today·2001
Same author

Research & development. Basic science and pharmaceutical innovation.

Nature biotechnology·1999

Advances in genomic sciences and molecular biology are revolutionizing drug discovery. This interdisciplinary approach enhances treatment options for complex diseases and transforms the pharmaceutical industry landscape.

Area of Science:

  • Pharmacology and Toxicology
  • Genetics and Genomics
  • Biotechnology

Background:

  • Drug research has historically driven medical progress, primarily through chemistry.
  • The integration of molecular biology and genomic sciences is profoundly impacting modern drug discovery.
  • Recombinant proteins and monoclonal antibodies have significantly expanded therapeutic options.

Observation:

  • Genomic sciences, coupled with bioinformatics, enable the elucidation of genetic underpinnings of multifactorial diseases.
  • This allows for the identification of precise molecular targets for novel therapeutics.
  • The complexity of drug research necessitates changes in its interdisciplinary structure.

Findings:

  • The biotech industry is emerging as a key player in drug discovery, acting as the 'discovery arm' for pharmaceutical companies.

Related Experiment Videos

  • Biotech firms facilitate technology transfer, bridging the gap between academic research and large-scale pharmaceutical development.
  • This evolution is reshaping the institutional framework of drug research.

    • Implications:

    • Future medicines will increasingly target the genetic basis of diseases, offering more personalized treatment strategies.
    • The collaborative model involving academia, biotech, and pharma is accelerating the development of innovative therapies.
    • This paradigm shift promises to further enhance the progress of medicine through targeted drug development.